Evidence map›Paper›PMID 34088320›Full record

ArticleCell communication and signaling : CCS2021

The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function.

Alessia Varone, Chiara Amoruso, Marcello Monti, Manpreet Patheja, Adelaide Greco, Luigi Auletta, Antonella Zannetti, Daniela Corda

Open access · goldAbstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alessia VaroneInstitute of Biochemistry and Cell Biology, National Research Council, Via Pietro Castellino 111, 80131, Naples, Italy. alessia.varone@ibbc.cnr.it.
Chiara AmorusoInstitute of Biochemistry and Cell Biology, National Research Council, Via Pietro Castellino 111, 80131, Naples, Italy.
Marcello MontiInstitute of Biochemistry and Cell Biology, National Research Council, Via Pietro Castellino 111, 80131, Naples, Italy.
Manpreet PathejaInstitute of Biochemistry and Cell Biology, National Research Council, Via Pietro Castellino 111, 80131, Naples, Italy.
Adelaide GrecoInterdipartimental Center of Veterinary Radiology, University of Naples Federico II, Via Delpino 1, 80137, Naples, Italy.
Luigi AulettaIRCCS SDN, Via Emanuele Gianturco 113, 80142, Naples, Italy.
Antonella ZannettiInstitute of Biostructures and Bioimaging, National Research Council, Via Tommaso De Amicis 95, 80145, Naples, Italy.
Daniela CordaInstitute of Biochemistry and Cell Biology, National Research Council, Via Pietro Castellino 111, 80131, Naples, Italy. daniela.corda@cnr.it.ORCID 0000-0002-3614-751X
Institute of Protein Biochemistry · ITInstitute of Biostructure and Bioimaging · ITSDN Istituto di Ricerca Diagnostica e Nucleare · IT

Funding

Associazione Italiana per la Ricerca sul Cancro IG18776
6 · The paper itself

Abstract

backgroundInvadopodia are actin-based cell-membrane protrusions associated with the extracellular matrix degradation accompanying cancer invasion. The elucidation of the molecular mechanisms leading to invadopodia formation and activity is central for the prevention of tumor spreading and growth. Protein tyrosine kinases such as Src are known to regulate invadopodia assembly, little is however known on the role of protein tyrosine phosphatases in this process. Among these enzymes, we have selected the tyrosine phosphatase Shp1 to investigate its potential role in invadopodia assembly, due to its involvement in cancer development.

methodsCo-immunoprecipitation and immunofluorescence studies were employed to identify novel substrate/s of Shp1AQ controlling invadopodia activity. The phosphorylation level of cortactin, the Shp1 substrate identified in this study, was assessed by immunoprecipitation, in vitro phosphatase and western blot assays. Short interference RNA and a catalytically-dead mutant of Shp1 expressed in A375MM melanoma cells were used to evaluate the role of the specific Shp1-mediated dephosphorylation of cortactin. The anti-invasive proprieties of glycerophosphoinositol, that directly binds and regulates Shp1, were investigated by extracellular matrix degradation assays and in vivo mouse model of metastasis.

resultsThe data show that Shp1 was recruited to invadopodia and promoted the dephosphorylation of cortactin at tyrosine 421, leading to an attenuated capacity of melanoma cancer cells to degrade the extracellular matrix. Controls included the use of short interference RNA and catalytically-dead mutant that prevented the dephosphorylation of cortactin and hence the decrease the extracellular matrix degradation by melanoma cells. In addition, the phosphoinositide metabolite glycerophosphoinositol facilitated the localization of Shp1 at invadopodia hence promoting cortactin dephosphorylation. This impaired invadopodia function and tumor dissemination both in vitro and in an in vivo model of melanomas.

conclusionThe main finding here reported is that cortactin is a specific substrate of the tyrosine phosphatase Shp1 and that its phosphorylation/dephosphorylation affects invadopodia formation and, as a consequence, the ability of melanoma cells to invade the extracellular matrix. Shp1 can thus be considered as a regulator of melanoma cell invasiveness and a potential target for antimetastatic drugs. Video abstract.

Indexed as

AnimalsCell Line, TumorCortactinExtracellular MatrixHumansInositol PhosphatesLung NeoplasmsMelanomaMiceMice, Inbred BALB CMice, NudeModels, BiologicalNeoplasm InvasivenessPhosphorylationProtein BindingProtein Tyrosine Phosphatase, Non-Receptor Type 6CortactinglycerylphosphoinositolInositol PhosphatesProtein Tyrosine Phosphatase, Non-Receptor Type 6CancerCortactinGlycerophosphoinositolsInvadopodiaPhosphoinositidesSrc homology region 2 domain-containing phosphatase-1 (Shp1)

Identifiers

PMID34088320
PMCPMC8176763
OpenAlexW3164846248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.